Stocks · Health care · Pharmaceutical Preparations

ARVINAS, INC.

ARVN Clue Score64
United States Fiscal year ends December CIK 0001655759 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Andrew Saik
24 Jun 2026
Chief Financial Officer
Sold on a plan
5,696
$8.16
$46.47K
Angela M Cacace
17 Jun 2026
Chief Scientific Officer
Sold on a plan
2,576
$7.60
$19.56K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 388,373
History held since 28 Sep 2018